SA

Shaikh Asif Shaikh Jalal

Active Director Director DIN 08291792
DIN 08291792 First appointment Feb 2024 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value •••• Premium profile

About Shaikh Asif Shaikh Jalal

Data last updated:

Shaikh Asif Shaikh Jalal is a Director at Indosia Pharmaceuticals Private Limited (since 2024). The company operates in Electrnoics. Indosia Pharmaceuticals Private Limited reported revenue of ₹29.8 Lakh (FY 2025).

DIN 08291792
Primary Designation Director
Industry Electrnoics
First Appointment 27 Feb 2024
Oldest Company Age 7 yrs
Largest company Indosia Pharmaceuticals Private Limited · ₹29.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Feb 20242018₹29.8 Lakh (FY 2025)Active

Board colleagues of Shaikh Asif Shaikh Jalal

Directorship timeline

Open interactive timeline →
Indosia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shaikh Asif Shaikh Jalal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shaikh Asif Shaikh Jalal

Shaikh Asif Shaikh Jalal currently holds 1 directorship: Indosia Pharmaceuticals Private Limited (Director, since 27 Feb 2024, revenue ₹29.8 Lakh (FY 2025)).

Shaikh Asif Shaikh Jalal was first appointed on 27 Feb 2024 as Director at Indosia Pharmaceuticals Private Limited.

The current boards of Shaikh Asif Shaikh Jalal's companies include Farid Shaikh Hamid Shaikh (Indosia Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available